| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |